kw.\*:("advanced myeloid leukemia")
Results 1 to 1 of 1
Selection :
A Phase 1 Dose-Escalation Study of ARRY-520, a Kinesin Spindle Protein Inhibitor, in Patients With Advanced Myeloid LeukemiasJEAN KHOURY, Hanna; GARCIA-MANERO, Guillermo; KARAN, Sharon et al.Cancer. 2012, Vol 118, Num 14, pp 3556-3564, issn 0008-543X, 9 p.Article